Medhat Khafagy
Impact in
- Urology top 10%
- Urological Disorders and Treatments
-
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Reconstructive Surgery and Microvascular Techniques
Papers in
- Co-authors
- M. N. El‐Bolkainy (2 shared papers)M. A. Mansour (1 shared paper)Maus W. Stearns (1 shared paper)Mona S. Abdellateif (4 shared papers)Ahmed Bayoumi (4 shared papers)Mohamed Samra (2 shared papers)Guy F. Robbins (1 shared paper)David Schottenfeld (1 shared paper)
- Journals
- Cancer (2 papers)Journal of Reconstructive Microsurgery (1 paper)British Journal of Urology (1 paper)Journal of Gastroenterology and Hepatology (1 paper)Medical Oncology (1 paper)
- Partner nations
- EgyptUnited StatesAustria
In The Last Decade
Medhat Khafagy
22 papers receiving 307 citations
Peers
Comparison fields: 5 of 64
- Urology 36
- Surgery 150
- Oncology 72
- Cancer Research 34
- Infectious Diseases 27
Countries citing papers authored by Medhat Khafagy
This map shows the geographic impact of Medhat Khafagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Medhat Khafagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Medhat Khafagy more than expected).
Fields of papers citing papers by Medhat Khafagy
This network shows the impact of papers produced by Medhat Khafagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Medhat Khafagy. The network helps show where Medhat Khafagy may publish in the future.
Co-authors
The 25 scholars most cited alongside Medhat Khafagy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1972 | 50 | |
| 2 | 2002 | 28 | |
| 3 | 2021 | 26 | |
| 4 | 2008 | 24 | |
| 5 | 1979 | 24 | |
| 6 | 2021 | 21 | |
| 7 | 1975 | 19 | |
| 8 | 1975 | 19 | |
| 9 | 1973 | 16 | |
| 10 | 2006 | 15 | |
| 11 | Clinicopathological, Biochemical and Microbiological Change on Grey Mullet Exposed to Cadmium Chloride | 2009 | 13 |
| 12 | Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26. | 1978 | 11 |
| 13 | 1987 | 9 | |
| 14 | Misonidazole in the preoperative and radical radiotherapy of bladder cancer. | 1980 | 9 |
| 15 | 2013 | 8 | |
| 16 | 1980 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2012 | 5 | |
| 19 | 2011 | 5 | |
| 20 | 2014 | 4 |
About Medhat Khafagy
Medhat Khafagy is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Infectious Diseases and Urology, having authored 23 papers that have together received 322 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Sarcoma Diagnosis and Treatment (3 papers), COVID-19 Clinical Research Studies (3 papers), Urological Disorders and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), COVID-19 and healthcare impacts (2 papers) and Urinary and Genital Oncology Studies (2 papers). The work is most often cited by research in Urology (36 citations), Surgery (150 citations), Oncology (72 citations), Cancer Research (34 citations) and Infectious Diseases (27 citations). Medhat Khafagy has collaborated with scholars based in Egypt, United States and Austria. Frequent co-authors include M. N. El‐Bolkainy, M. A. Mansour, Maus W. Stearns, Mona S. Abdellateif, Ahmed Bayoumi, Mohamed Samra, Guy F. Robbins, David Schottenfeld, Rashad S. Barsoum and Hassan K. Awwad. Their work appears in journals such as Cancer, Journal of Reconstructive Microsurgery, British Journal of Urology, Journal of Gastroenterology and Hepatology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.